To test this hypothesis, we first identified the specific SCF E3 ligases and their potential pathobiological partners, and then explore their mechanisms in driving BRCA progression, with a view to understanding how the SCF E3 ubiquitin ligases might act as significant risk factors in cancer advancement [13]. Here, KITLG is linked to cancer.